A feasibility study of bevacizumab plus dose-dense doxorubicin-cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel in early-stage breast cancer (Q37197579)
Jump to navigation
Jump to search
scientific article published on 24 February 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A feasibility study of bevacizumab plus dose-dense doxorubicin-cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel in early-stage breast cancer |
scientific article published on 24 February 2011 |
Statements
1 reference
A feasibility study of bevacizumab plus dose-dense doxorubicin-cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel in early-stage breast cancer (English)
1 reference
Monica Morrow
1 reference
Hope Rugo
1 reference
Michelle Melisko
1 reference
Mark Moasser
1 reference
Heather L McArthur
1 reference
Benjamin Nulsen
1 reference
Laura Hawks
1 reference
Jill Grothusen
1 reference
Matthew Paulson
1 reference
Tiffany Traina
1 reference
Sujata Patil
1 reference
Qin Zhou
1 reference
Richard Steingart
1 reference
Chau Dang
1 reference
Peter Cordeiro
1 reference
Monica Fornier
1 reference
John Park
1 reference
Andrew Seidman
1 reference
Diana Lake
1 reference
Theresa Gilewski
1 reference
Maria Theodoulou
1 reference
Gabriella D'Andrea
1 reference
Nancy Sklarin
1 reference
Steven Sugarman
1 reference
Jane E Sealey
1 reference
John H Laragh
1 reference
Carmen Merali
1 reference
Clifford A Hudis
1 reference
Maura N Dickler
1 reference
24 February 2011
1 reference
1 reference
3398-3407
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference